Icon.jpg
 

Who We Are

At Limitless Ventures, we are independent impact investors focused on solving deeply entrenched societal challenges—particularly Mental Health and Substance Use Disorder. These issues persist not due to a lack of solutions, but because the system is fundamentally misaligned. We believe that true progress requires aligning all stakeholders—patients, providers, and payers—while generating sustainable financial returns.

To achieve this, we take a lifecycle approach and have built a uniquely structured investment platform. We partner with top-tier teams across Venture Capital, Private Equity, and Real Estate while integrating an in-house medical team to bridge the gap between financial incentives and patient outcomes. Every investment we make is structured as a Special Purpose Vehicle (SPV), ensuring flexibility, focus, and accountability.

Our Impact & Vision

Since 2017, we have invested $30M+ across 27 transactions, generating $16M in Distributions to Paid-In Capital (DPI/O’d) while positively impacting 120,000+ lives. Our mission is ambitious but clear:

  • Improve 500,000 lives in the U.S. by 2030

  • Impact 1% of the mental health population (~4 million people) by 2040

We achieve this through investments across three interconnected asset classes:

  • Venture Capital – Backing early-stage innovation

  • Buyout (Private Equity) – Scaling proven models

  • Real Estate – Creating infrastructure for long-term change

Why Mental Health & Addiction Persist

Mental health is both deeply personal and highly systemic—which is why one-size-fits-all solutions fail. Some of the biggest barriers to change include:

1) The Snowflake Problem

Every person struggling with mental health or addiction is unique—like a snowflake. But at scale, they are all snowflakes—part of a massive and fragmented market:

  • Total Addressable Market (TAM): 60M+ people

  • Serviceable Addressable Market (SAM): 20M+ people

  • Serviceable Obtainable Market (SOM): 2M+ people

The challenge is creating systems that can scale without losing personalization.

2) Stakeholder Misalignment

Patients need care. Providers want to help. Payers manage risk. But their incentives rarely align.

  • Patients want access to treatment.

  • Providers need financial sustainability.

  • Payers (insurers) profit by minimizing payouts.

This misalignment leads to gaps in care, inadequate treatment, and financial inefficiencies.

3) Uninvestable Complexity

Mental health is not just a healthcare issue—it spans biotech, real estate, workforce development, public markets, and social services. Investing in solutions requires expertise across multiple disciplines and industries, which few investors possess.

4) The Long Tail of Solutions

History shows that solving major public health crises takes generations, not years.

  • Alcoholism began over 2,000 years ago when alcohol was the safest liquid to drink.

  • Waterborne diseases (cholera, typhoid, dysentery) plagued societies until 1899, when Kohler Water Works introduced the bubbler, making clean water widely available.

Mental health solutions have similar long time horizons (20+ years), which don't fit neatly into traditional investment mandates.

5) Incumbent Resistance: The Alcohol & Tobacco Playbook

Many industries don’t just resist disruption—they actively perpetuate the problem.

  • Alcohol has grown at a 10% CAGR from $300M in 1933 to $1.7T in 2023.

  • Tobacco has sustained a 3.28% CAGR from $5B in 1933 to $75B in 2023.

These industries don’t disappear—they evolve (e.g., vaping, cannabis, "healthier" alcohol alternatives). Meanwhile, mental health solutions struggle for funding, even as the market grows.


Our Lifecycle Approach: Investing Across the Continuum

To break these cycles, we invest across the full continuum of problems and solutions, aligning value-based outcomes with financial returns. Our framework is inspired by the Determinants of Health (DoH) model defined by the CDC, broken into three major investment categories:

Innovation: typically [Seed ($250K)/Series A ($500K)] VC Preferred Equity:

  • Life Sciences (i.e: biotech and medical devices for poly-substance abuse)

  • Technology (i.e: Software/AI making at-home-healthcare better)

  • Internet of Things (i.e: Smart watch which provides behavioral data)

Distribution: typically Private Equity (70% Pref. Equity) on $1-4M EBITDA.

  • Treatment (i.e: Detox, PHP, IoP, OP)

  • Professional Development (i.e: Skill upleveling, Re-entry placement)

Longevity: typically Real Estate Ground-Up Projects (200k to 500k Sq.Ft.)

  • Wellness housing (i.e.: Mixed-Use multi-family in Urban enviornments)

  • Food as Medicine (i.e: Organic Food at In-Organic prices)

By timing investments correctly and integrating expertise across disciplines, we create sustainable change while generating uncorrelated, high-alpha returns

History

Generally, but not explicitly, we focus our time energy and effort on deals within the fields of we have domain expertise. Some indications of deals we have funded in the past include the following areas:

Healthcare:

  • Depression

  • Suicidal Ideation

  • Bi-Polar

  • Substance Use Disorder (Alcohol, Opioids, Cocaine & Nicotine)

  • Process Addictions (Obesity, Gambling, Gaming)

  • Covid-19

  • Parkinsons

  • Kidney Disease

Investment Criteria: What We Look For

We back mission-driven companies that meet these key criteria:

Market: Large, growing, and unmet need
Solution: Unique, defensible, and scalable
Economics: Strong unit economics and financial sustainability
Team: Led by repeat entrepreneurs with successful exits
Resources: Backed by institutional capital with domain expertise

As active partners, we go beyond capital—taking board seats, advisory roles, and operational positions to drive execution and impact.

As a team who is seeking people with a partner mindset, we are relentlessly focused on mutual success. Therefore, we often role up our sleeves, take board seats, advisory positions or CxO roles while leveraging our network to drive unparalleled access, insights and operational execution.

Performance & Track Record

  • Median time to capital return: 2.25 years

  • Investor DPI: Up to 2.4x within this timeframe

  • TVPI/O: $18M/$16.75M

  • Transactions/Unqiue Deals: 34/20

  • Timeline: 12–16 weeks

  • Governance: Approval by Medical Team → Investment Committee → LPAC

  • Historical structure: 1/3 lead, 1/3 co-lead, 1/3 follow-on from institutional investors

Values

We believe in "radical responsibility" with our capital, time, and expertise. Our values prioritize:

  • De-risking in the short-run (use Non-Dilutive capital, Diversification through Ef

  • Maximize the Effiency Frontier over the long-run (identify positions to supersize through major co-investing)

  • Positive Externalities—creating win-win solutions for stakeholders and shareholders/investors.

Final Thought

We’re not just investing in companies. We’re investing in change.

We welcome conversations with mission-aligned partners who share our vision. If you believe in doing good by doing well, let’s talk.


Sincerely,

Limitless Ventures Management Team

Mantra: Healthy People, Healthy Planet

Email: info@limitlessventures.us